Browse Category

Stock Market News News 22 December 2025 - 23 December 2025

Western Digital (WDC) Stock After Hours on Dec. 22, 2025: Nasdaq-100 Debut, Today’s Headlines, Analyst Forecasts, and What to Watch Before Tuesday’s Open

Western Digital (WDC) Stock After Hours on Dec. 22, 2025: Nasdaq-100 Debut, Today’s Headlines, Analyst Forecasts, and What to Watch Before Tuesday’s Open

Western Digital Corporation (NASDAQ: WDC) is ending Monday’s session in the spotlight—but not for a simple “up day.” The stock closed regular trading on Dec. 22 at $176.76, down 2.39%, and then held roughly steady in after-hours action. Finviz+1 Why the heightened attention? Today was Western Digital’s first session as a newly added member of the Nasdaq-100, a structural change that can influence liquidity, passive flows, and short-term volatility—especially during a holiday-shortened week. Investing.com+1 Below is a detailed, news-driven breakdown of what happened after the bell on 22.12.2025, what’s driving the narrative right now, and what to keep on the
CRH PLC Stock After Hours Today (Dec. 22, 2025): S&P 500 Debut, Fresh Buyback Disclosure, and What to Know Before Tuesday’s Market Open

CRH PLC Stock After Hours Today (Dec. 22, 2025): S&P 500 Debut, Fresh Buyback Disclosure, and What to Know Before Tuesday’s Market Open

CRH PLC (NYSE: CRH) ended Monday’s session with a steady, index-driven tone as the building materials giant completed its first day as an S&P 500 constituent and investors digested a new “Transaction in Own Shares” buyback update released earlier today. Heading into Tuesday’s open (Dec. 23, 2025), the setup is less about a single headline catalyst and more about liquidity, index flows, and macro data risk in a holiday-shortened week. CRH stock price after the bell: where shares closed and what after-hours is saying CRH shares closed at $126.22 at 4:00 p.m. ET, up $1.80 (+1.45%) on the day. The
NextEra Energy (NEE) Stock News Today: AI Data Center Deals, 2026 Earnings Outlook, and Analyst Price Targets (Dec. 22, 2025)

NextEra Energy (NEE) Stock News Today: AI Data Center Deals, 2026 Earnings Outlook, and Analyst Price Targets (Dec. 22, 2025)

NextEra Energy, Inc. (NYSE: NEE) enters the final full week of 2025 with an unusual mix of catalysts that touch nearly every part of the U.S. power value chain: regulated utility rate clarity in Florida, a rapidly expanding portfolio tied to Big Tech’s data-center buildout, and a wave of analyst notes trying to re-price what “growth” means for a company that historically sat in the utility bucket. As of Dec. 22, investors are parsing a central question: can NextEra keep delivering above-average earnings growth while navigating rising grid constraints, shifting federal permitting dynamics, and a capital-intensive pipeline that is increasingly
Biogen (BIIB) Stock News Today (Dec. 22, 2025): QALSODY Data, Nasdaq-100 Exit, and Analyst Forecasts

Biogen (BIIB) Stock News Today (Dec. 22, 2025): QALSODY Data, Nasdaq-100 Exit, and Analyst Forecasts

Biogen Inc. (NASDAQ: BIIB) is in focus on Monday, December 22, 2025—a day that combines company-specific clinical headlines with a major index event for the stock. Investors are weighing fresh long‑term data for QALSODY (tofersen) in a rare genetic form of ALS, Biogen’s public statement honoring co‑founder Charles Weissmann, and the market mechanics of Biogen’s removal from the Nasdaq‑100, which becomes effective today. At the same time, Wall Street’s outlook remains mixed but active: recent analyst notes span “Reduce/Hold” to “Outperform” with price targets stretching from the low‑$140s to above $200, reflecting a debate over how quickly newer products—especially Leqembi
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $14.50 Cash Buyout, Analyst Downgrades, and What Investors Watch Next (Dec. 22, 2025)

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is trading like a classic “deal stock” on December 22, 2025—hovering just below a fixed cash acquisition price after BioMarin Pharmaceutical (NASDAQ: BMRN) agreed to buy the company in an all-cash transaction. As of the latest available trade on Dec. 22, FOLD is around $14.22, with the market effectively pricing in the probability, timing, and risk of the merger closing—rather than the stand-alone upside of Amicus’ rare disease commercial portfolio. Below is a detailed roundup of the current news, forecasts, and analyst/market commentary shaping Amicus stock on 22.12.2025—and the specific catalysts that can still move
Seagate Technology (STX) Stock News Today: Nasdaq-100 Inclusion, Dividend Date, Earnings Forecasts and Analyst Price Targets (Dec. 22, 2025)

Seagate Technology (STX) Stock News Today: Nasdaq-100 Inclusion, Dividend Date, Earnings Forecasts and Analyst Price Targets (Dec. 22, 2025)

Seagate Technology Holdings plc (NASDAQ: STX) is starting the week in the spotlight for three reasons that matter to stock investors: it officially joined the Nasdaq-100 index today, it has a fresh quarterly dividend with an imminent ex-dividend date, and Wall Street is building expectations for the company’s next earnings update as the AI-driven data-storage cycle keeps reshaping demand. Despite the headline boost of index inclusion, STX shares are lower in Monday trading. As of the latest trade on December 22, 2025, Seagate stock is around $283.17, down about 4.45% on the day, after trading between $279.50 and $302.40. Below
BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025

BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025

BillionToOne, Inc. (NASDAQ: BLLN) is still in the “fresh IPO” phase where price discovery happens in public—loudly. On December 22, 2025, the molecular diagnostics company’s shares were trading at $97.36, down about 5.1% on the session, after opening above $103 and swinging through a $96.61–$103.85 intraday range. There wasn’t a new company press release dated today that materially changed the story. Instead, BLLN’s move looks like part of the normal churn that follows a high-profile debut: early enthusiasm, analyst initiations, earnings/guidance digestion, and then a tug-of-war between “this could be huge” and “but how much is already priced in?” Below
Academy Sports and Outdoors Stock (ASO) Drops on Dec. 22, 2025: Nike Shockwaves, Q3 Results, Updated Guidance, Analyst Price Targets, and 2026 Forecasts

Academy Sports and Outdoors Stock (ASO) Drops on Dec. 22, 2025: Nike Shockwaves, Q3 Results, Updated Guidance, Analyst Price Targets, and 2026 Forecasts

Academy Sports and Outdoors, Inc. (NASDAQ: ASO) stock traded lower on Monday, December 22, 2025, as a mix of sector headlines and company-specific fundamentals collided—again reminding investors that retail is where macro nerves go to get amplified. As of the latest available trading data, ASO was around $51.21, down about 4.64% on the day, with a market cap near $3.45 billion. The down move comes even though Academy’s most recent quarterly report showed improving profitability and a narrowed full-year outlook. So what’s driving the weakness today, what do the latest forecasts say, and how is Wall Street positioning into 2026?
Globalstar Stock (GSAT) Surges on Dec. 22, 2025: Latest News, Apple Partnership, Analyst Targets, and What Investors Are Watching Next

Globalstar Stock (GSAT) Surges on Dec. 22, 2025: Latest News, Apple Partnership, Analyst Targets, and What Investors Are Watching Next

Globalstar, Inc. (NASDAQ: GSAT) is back in motion on Monday, December 22, 2025, with the satellite-and-spectrum name seeing a notable bounce after a choppy mid-December pullback. As of the latest available trading data, GSAT was trading around the mid-$60s per share, up roughly 6%–7% on the day, after moving between the low-$60s and upper-$60s intraday. StockAnalysis+1 That pop isn’t happening in a vacuum. Over the past several weeks, Globalstar has stacked up a headline cocktail that investors love and fear in equal measure: Apple-linked satellite connectivity, private 5G ambitions using Band n53, fresh analyst coverage and price targets, and lingering
Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma (ZBIO) Stock Hits a Record High on Dec. 22, 2025 as INDIGO Phase 3 Catalyst Nears — Latest News, Analyst Forecasts, and What’s Next

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is having one of those classic biotech days where the market starts acting like it can see the future. On Monday, December 22, 2025, ZBIO surged roughly 14% and traded around $41.23 by early afternoon Eastern time—after touching a fresh all-time high near $41.67, according to multiple market data reports. MarketBeat+1 The timing isn’t subtle: Zenas is approaching a pivotal clinical-data moment for its lead asset obexelimab, and Wall Street research desks are increasingly framing the stock as a near-term catalyst setup—high potential reward, high potential whiplash. Below is a full roundup of the news,
Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard Incorporated (NYSE: MA) is starting the week in focus after a fresh wave of payments-industry headlines put the company’s long-term growth narrative—digital commerce, tokenization, B2B payments, and AI-enabled checkout—back in the spotlight. As of Dec. 22, 2025 (17:00 UTC), Mastercard stock was trading around $576.90, up about 0.8% on the day, after touching an intraday high near $579.40. Below is a detailed look at what’s driving the conversation around MA stock today, the most important catalysts investors are watching, and how current forecasts and analyst expectations are shaping the risk/reward setup into 2026. Mastercard stock price action: what investors
Rigetti Computing Stock (RGTI) News Today, Dec. 22, 2025: Shares Surge as Analyst Forecasts for 2026 Focus on Roadmap, Cash Runway, and High-Volatility Risks

Rigetti Computing Stock (RGTI) News Today, Dec. 22, 2025: Shares Surge as Analyst Forecasts for 2026 Focus on Roadmap, Cash Runway, and High-Volatility Risks

Rigetti Computing, Inc. (NASDAQ: RGTI) is back in the spotlight on Monday, December 22, 2025, as quantum-computing stocks regain momentum. RGTI traded around $27 in Monday’s session, up roughly 14% on the day—another reminder that quantum “pure plays” can move fast in both directions. Finviz The renewed attention isn’t coming from a single headline. Instead, it’s being driven by a dense cluster of fresh stock-focused commentary published today—including a Zacks deep dive into estimates and valuation, a TipRanks roundup of what Wall Street expects for 2026, and a Motley Fool/Nasdaq comparison of Rigetti versus IonQ. Finviz+2TipRanks+2 Below is a detailed
1 16 17 18 19 20 51

Stock Market Today

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.02.2026

7 February 2026
LIVEMarkets rolling coverageStarted: February 7, 2026, 12:00 AM ESTUpdated: February 7, 2026, 12:49 AM EST CSL Faces Growth Uncertainty Amid Seqirus Spin-off Pause and Flu Vaccine Demand Drop February 7, 2026, 12:49 AM EST. CSL (ASX:CSL) confronts near-term challenges after delaying its Seqirus vaccine unit spin-off due to weaker U.S. flu vaccination uptake, impacting its fiscal 2026 growth outlook. Regulatory scrutiny in Europe over its Tavneos kidney therapy data, plus intensifying U.S. competition for its Vifor iron products, heighten concerns over product credibility and pricing pressure. Despite these headwinds, CSL's diversified portfolio in plasma, vaccines, and kidney therapies underpins its
Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop